(Q40070964)

17 September 2017

title

Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study (English)

1 reference

17 September 2017

main subject

venous thromboembolism

1 reference

3

Dawn Dowding

0 references

Simon Noble

object named as

Simon Noble

4

0 references

Miriam J Johnson

object named as

Miriam Johnson

7

0 references

author name string

Laura Sheard

1

1 reference

17 September 2017

Hayley Prout

2

1 reference

17 September 2017

Ian Watt

5

1 reference

17 September 2017

Anthony Maraveyas

6

1 reference

17 September 2017

publication date

23 October 2012

1 reference

17 September 2017

1 reference

17 September 2017

volume

27

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

339-348

1 reference

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Epidemiology and pathophysiology of cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

The challenges of managing cancer related venous thromboembolism in the palliative care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Personal paper. Beliefs and evidence in changing clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Implementing national guidelines at local level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216312461678

21 January 2018

Identifiers

DOI

10.1177/0269216312461678

1 reference

17 September 2017

1 reference